Quantitative assessment of neuroleptic-induced extrapyramidal symptoms: clinical and nonclinical approaches.
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000503:physiopathology; D001767:Blinking / Q000187:drug effects; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology; D004576:Electromyography; D006801:Humans; D006816:Huntington Disease / Q000503:physiopathology; D008875:Middle Aged; D012907:Smoking; D014202:Tremor / Q000503:physiopathology
D014150:Antipsychotic Agents